Novo Nordisk’s Wegovy Weight Loss Drug Has Seen a Meteoric Rise in Popularity.
Nurphoto | Getty Images
Novo Nordisk On Wedsday said it will offer its weight loss weight wegovy for less than half of its usual price per month through a new direct-to-combmer online paharmacy.
The Cash-PayOffering is available to millions of patients without insurance coverage for the blockbuster injection, Such as that with Medicare. The pharmacy, called novocare, will allow patients to pay $ 499 in cash per month for the weekly drug.
Wegovy’s list price before insurance and other rebates is almost $ 1,350 per month,
The Danish Drugmaker’s Move Follows a similar strategy from its main rival eli lilly. The two companies are fighting to dominate the market for so-called GLP-1s, which mimic certain gut hormones to suppress appetiite and regulate blood sugar.
Eli lilly in January 2024 launchedIts OWN Direct-to-Consumer Online Pharmacy, LillyDirect, to Help Patients Access its weight loss drug zepbound.
The website allows eligible patients to get a prescription through a telehealth provider and can provide home delivery. More recently, LillyDirect also started with the offering zepbound in Single-dose vials That are half or even less of its usual $ 1,000 monthly list price.
This story is developing. Please check back for updates.
(Tagstotranslate) Breaking News: Business (T) Health Care Industry (T) Pharmaceuticals (T) Biotech and Pharmaceuticals (T) Biotechnology (T) Business (T) Business (T) Business (T) Novo Novo Novo NORORISK A/s